Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2005
08/10/2005CN1651018A Medicinal composition for treating upper respiration duct infection, its preparation method and quality control method
08/10/2005CN1651005A Chinese medicinal composition containing corrigent and its preparation method
08/10/2005CN1650977A Chinese medicine for treating nasitis
08/10/2005CN1650956A Peppermint oil drop pill and its making method
08/10/2005CN1650944A Decoction for treating throat-almond
08/10/2005CN1650940A Chinese herbal medicine for treating cypridopathy, avariosis, aids and virus infection SARS
08/10/2005CN1650919A Prescription of Chinese medicine compound preparation, its preparation method and use
08/10/2005CN1650912A Chinese medicinal preparation for treating lung fibrosis
08/10/2005CN1650908A Method of extracting total flavone product from halenalin plant full flower
08/10/2005CN1650903A Method of extracting roice clearing medicament from effective component in natural plant Chinese medicine
08/10/2005CN1650897A Method of extracting heat clearing toxin resoluing medicine from natural plant Chinese medicine effective component
08/10/2005CN1650890A Child metho kahuangmin effervescent granules and its making method
08/10/2005CN1650889A Child cough stopping sgrup and its preparation method
08/10/2005CN1650868A Compound medicinal preparation for treating pneumonia infection disease and its preparation method
08/10/2005CN1650863A Antibiotic compositions for treatment of the eye, ear and nose
08/10/2005CN1650848A Clenbuterol hydrochloride inhaling powder mist agent for treating asthma
08/10/2005CN1650847A Albuterol time controlling pulse slow release oral preparation and its preparation method
08/10/2005CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof
08/10/2005CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214007C Cyclopentanoindoles, compositions containing such compounds and methods of treatment
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213900C Method and apparatus for filling powder into container
08/10/2005CN1213759C Chinese medicine granule for treating chronic pharyngitis and its prepn process
08/10/2005CN1213752C Treating allergic and inflammatory diseases
08/10/2005CN1213742C Pharmaceutical control of inflammation
08/10/2005CN1213741C New formulation for inhalation having poured bulk density of from 0.28to 0.38g/ml, comprising formoterol
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927222 Compounds
08/09/2005US6927221 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926178 Valve with a two-component seal
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2249330C Method of treating heart failure with endothelin antagonists
08/09/2005CA2095659C Heteroatoms-containing tricyclic compounds
08/04/2005WO2005034929A3 Tissue remodeling and vascularization
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171350 Benzhydryl derivatives
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171345 Pteridine compounds for the treatment of psoriasis
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
08/04/2005US20050171152 N-( alpha -ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide; neurokinin NK-3 receptor antagonists; chemical intermediates; efficient process with increased yields; coupling an ortho-hydroxy acid with an amine; easy conversion side-product to desired; CNC disorders; anxiolitic and antidepressant
08/04/2005US20050171149 antioxidant properties and peroxisome proliferator activated receptors (PPAR) alpha and PPAR gamma activator properties; cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms, neurodegenerative, and skin disorders
08/04/2005US20050171143 selective Chemoattractant receptor-homologous molecule expressed on Th2 cells ( CRTH2 receptor) antagonist; activities for eosinphil and basophil infiltration; indol/carbazol-sulfonamide derivatives; antiallergenic agent; asthma, allergic rhinitis and dermatitis, polyarteritis, autoimmune disease
08/04/2005US20050171129 Polycyclic guanine derivative phosphodiesterase V inhibitors
08/04/2005US20050171128 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2005US20050171125 Novel alkoxypyridine-derivatives
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171119 Two-layer tablet of efletirizine (2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid) containing an immediate release layer and a time-release layer for once daily dosage; antihistamine, bronchodilator and antispasmodic agent
08/04/2005US20050171117 Preparation of pharmaceutical salts
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/04/2005US20050171083 Modified release pharmaceutical formulation
08/04/2005US20050171078 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene
08/04/2005US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity
08/04/2005US20050171068 Novel 4-dedimethylaminotetracycline derivatives
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050170365 Nucleotide sequences coding modified deoxyribonuclease for treatment of pulmonary, autoimmune and/or cystic fibrosis
08/04/2005US20050169983 Chewable soft capsule
08/04/2005US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability
08/04/2005CA2553010A1 Thiazole derivatives as a2b antagonists
08/04/2005CA2552784A1 Beta-2-agonists, and their use as medicaments
08/03/2005EP1559716A1 Pyrazolonaphthyridine derivative
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558614A1 Pyridopyrrolizine and pyridoindolizine derivatives
08/03/2005EP1558604A1 Quaternary ammonium compounds and their use as antimuscarinic agents
08/03/2005EP1558563A1 Quaternary ammonium compounds
08/03/2005EP1558273A2 Treatment and prevention of pulmonary conditions
08/03/2005EP1558262A1 Water-soluble meloxicam granulates
08/03/2005EP1558252A2 Substituted furo 2,3-b] pyridine derivatives
08/03/2005EP1558249A1 Use of tacrolimus (fk506) derivatives combined with beta2-agonists for the treatment of asthma
08/03/2005EP1558213A2 Mucoadhesive tetracycline formulations
08/03/2005EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1280527B1 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP0844869B1 Ulmwh (ultra-low-molecular weight heparin) for treating asthma
08/03/2005CN1649884A Novel azacyclic ethynyl derivatives
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 878